PMID- 29053933 OWN - NLM STAT- MEDLINE DCOM- 20180831 LR - 20180831 IS - 1715-5320 (Electronic) IS - 1715-5312 (Linking) VI - 43 IP - 3 DP - 2018 Mar TI - Chronic administration of ellagic acid improved the cognition in middle-aged overweight men. PG - 266-273 LID - 10.1139/apnm-2017-0583 [doi] AB - This study aimed to investigate if ellagic acid has beneficial effects on cognitive deficits in middle-aged overweight individuals and to propose a possible mechanism. A total of 150 middle-aged male participants, including 76 normal-weight and 74 overweight men, aged between 45 to 55 years, were recruited for this study. Both normal-weight and overweight participants were administered either 50 mg ellagic acid or placebo cellulose daily for 12 weeks. Blood lipids, peripheral brain-derived neurotrophic factor (BDNF), and saliva cortisol were assessed on the last day of the procedure to investigate the effects induced by ellagic acid. The results revealed that ellagic acid treatment improved the levels of blood lipid metabolism with a 4.7% decline in total cholesterol, 7.3% decline in triglycerides, 26.5% increase in high-density lipoprotein, and 6.5% decline in low-density lipoprotein. Additionally, ellagic acid increased plasma BDNF by 21.2% in the overweight group and showed no effects on normal-weight participants. Moreover, the increased saliva cortisol level in overweight individuals was inhibited by 22.7% in a 12-week ellagic acid treatment. Also, compared with placebo, overweight individuals who consumed ellagic acid showed enhanced cognitive function as measured by the Wechsler Adult Intelligence Scale-Revised and the Montreal Cognitive Assessment. To the best of our knowledge, this is the first report showing that ellagic acid prevents cognitive deficits through normalization of lipid metabolism, increase in plasma BDNF level, and reduction of saliva cortisol concentration. These results indicate that ellagic acid has a potential to restore cognitive performance related to mild age-related declines. FAU - Liu, Ying AU - Liu Y AD - a Beijing Key Lab of Chinese Materia Medica Quality Evaluation, School of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing 100102, PR China. FAU - Yu, Shuyi AU - Yu S AD - b College of Pharmacy & Center on Translational Neuroscience, Minzu University of China, Beijing 100081, PR China. FAU - Wang, Fen AU - Wang F AD - c Heilongjiang Nursing College, Heilongjiang, 150086, PR China. FAU - Yu, Haitao AU - Yu H AD - d Qiqihar Medical University, Qiqihar 161006, PR China. FAU - Li, Xueli AU - Li X AD - e Experimental Research Center, China Academy of Traditional Chinese Medicine, Beijing, 100700, PR China. FAU - Dong, Wanru AU - Dong W AD - f Heilongjiang University of Chinese Medicine, Heilongjiang, 150040, PR China. FAU - Lin, Ruichao AU - Lin R AD - a Beijing Key Lab of Chinese Materia Medica Quality Evaluation, School of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing 100102, PR China. FAU - Liu, Qingshan AU - Liu Q AD - b College of Pharmacy & Center on Translational Neuroscience, Minzu University of China, Beijing 100081, PR China. LA - eng PT - Journal Article PT - Randomized Controlled Trial DEP - 20171020 PL - Canada TA - Appl Physiol Nutr Metab JT - Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme JID - 101264333 RN - 19YRN3ZS9P (Ellagic Acid) RN - WI4X0X7BPJ (Hydrocortisone) SB - IM MH - Cognition/*drug effects MH - Double-Blind Method MH - Ellagic Acid/*pharmacology MH - Humans MH - Hydrocortisone/chemistry MH - Male MH - Middle Aged MH - *Overweight MH - Saliva/chemistry OTO - NOTNLM OT - acide ellagique OT - brain-derived neurotrophic factor (BDNF) OT - cholesterol OT - cholesterol OT - cognition OT - cortisol OT - ellagic acid OT - facteur neutrophique derive du cerveau (BDNF) OT - lipoprotein OT - lipoproteines OT - midlife overweight OT - surpoids au mi-temps de la vie EDAT- 2017/10/21 06:00 MHDA- 2018/09/01 06:00 CRDT- 2017/10/21 06:00 PHST- 2017/10/21 06:00 [pubmed] PHST- 2018/09/01 06:00 [medline] PHST- 2017/10/21 06:00 [entrez] AID - 10.1139/apnm-2017-0583 [doi] PST - ppublish SO - Appl Physiol Nutr Metab. 2018 Mar;43(3):266-273. doi: 10.1139/apnm-2017-0583. Epub 2017 Oct 20.